Literature DB >> 24335958

Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation.

Kongming Wu1, Ke Chen, Chenguang Wang, Xuanmao Jiao, Liping Wang, Jie Zhou, Jing Wang, Zhiping Li, Sankar Addya, Poul H Sorensen, Michael P Lisanti, Andrew Quong, Adam Ertel, Richard G Pestell.   

Abstract

The epithelial-mesenchymal transition (EMT) enhances cellular invasiveness and confers tumor cells with cancer stem cell-like characteristics, through transcriptional and translational mechanisms. The mechanisms maintaining transcriptional and translational repression of EMT and cellular invasion are poorly understood. Herein, the cell fate determination factor Dachshund (DACH1), suppressed EMT via repression of cytoplasmic translational induction of Snail by inactivating the Y box-binding protein (YB-1). In the nucleus, DACH1 antagonized YB-1-mediated oncogenic transcriptional modules governing cell invasion. DACH1 blocked YB-1-induced mammary tumor growth and EMT in mice. In basal-like breast cancer, the reduced expression of DACH1 and increased YB-1 correlated with poor metastasis-free survival. The loss of DACH1 suppression of both cytoplasmic translational and nuclear transcriptional events governing EMT and tumor invasion may contribute to poor prognosis in basal-like forms of breast cancer, a relatively aggressive disease subtype.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24335958      PMCID: PMC3933065          DOI: 10.1158/0008-5472.CAN-13-2466

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression.

Authors:  Karsten Jurchott; Stephan Bergmann; Ulrike Stein; Wolfgang Walther; Martin Janz; Isabella Manni; Giulia Piaggio; Ellen Fietze; Manfred Dietel; Hans-Dieter Royer
Journal:  J Biol Chem       Date:  2003-04-14       Impact factor: 5.157

Review 2.  Masking of mRNA by Y-box proteins.

Authors:  J Sommerville; M Ladomery
Journal:  FASEB J       Date:  1996-03       Impact factor: 5.191

3.  The p63 protein isoform ΔNp63α modulates Y-box binding protein 1 in its subcellular distribution and regulation of cell survival and motility genes.

Authors:  Antonella Di Costanzo; Annaelena Troiano; Orsola di Martino; Andrea Cacace; Carlo F Natale; Maurizio Ventre; Paolo Netti; Sergio Caserta; Alessandra Pollice; Girolama La Mantia; Viola Calabrò
Journal:  J Biol Chem       Date:  2012-07-11       Impact factor: 5.157

4.  The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling.

Authors:  Vladimir M Popov; Jie Zhou; L Andrew Shirley; Judy Quong; Wen-Shuz Yeow; Jennifer A Wright; Kongming Wu; Hallgeir Rui; Ratna K Vadlamudi; Jie Jiang; Rakesh Kumar; Chenguang Wang; Richard G Pestell
Journal:  Cancer Res       Date:  2009-07-15       Impact factor: 12.701

5.  The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth.

Authors:  Kongming Wu; Sanjay Katiyar; Agnes Witkiewicz; Anping Li; Peter McCue; Liang-Nian Song; Lifeng Tian; Ming Jin; Richard G Pestell
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

Review 6.  YB-1: oncoprotein, prognostic marker and therapeutic target?

Authors:  Annette Lasham; Cristin G Print; Adele G Woolley; Sandra E Dunn; Antony W Braithwaite
Journal:  Biochem J       Date:  2013-01-01       Impact factor: 3.857

7.  Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8.

Authors:  Kongming Wu; Sanjay Katiyar; Anping Li; Manran Liu; Xiaoming Ju; Vladimir M Popov; Xuanmao Jiao; Michael P Lisanti; Antonella Casola; Richard G Pestell
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-08       Impact factor: 11.205

8.  Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth.

Authors:  Maofu Fu; Mahadev Rao; Chenguang Wang; Toshiyuki Sakamaki; Jian Wang; Dolores Di Vizio; Xueping Zhang; Chris Albanese; Steven Balk; Chawnshang Chang; Saijun Fan; Eliot Rosen; Jorma J Palvimo; Olli A Jänne; Selen Muratoglu; Maria Laura Avantaggiati; Richard G Pestell
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

9.  Acetylation of the cell-fate factor dachshund determines p53 binding and signaling modules in breast cancer.

Authors:  Ke Chen; Kongming Wu; Michael Gormley; Adam Ertel; Jing Wang; Wei Zhang; Jie Zhou; Gabriele Disante; Zhiping Li; Hallgeir Rui; Andrew A Quong; Steven B McMahon; Haiteng Deng; Michael P Lisanti; Chenguang Wang; Richard G Pestell
Journal:  Oncotarget       Date:  2013-06

10.  YB-1 is a Transcription/Translation Factor that Orchestrates the Oncogenome by Hardwiring Signal Transduction to Gene Expression.

Authors:  Joyce Wu; Anna L Stratford; Arezoo Astanehe; Sandra E Dunn
Journal:  Transl Oncogenomics       Date:  2007-05-11
View more
  38 in total

1.  Overexpression of YB1 and EZH2 are associated with cancer metastasis and poor prognosis in renal cell carcinomas.

Authors:  Yong Wang; Yajing Chen; Hua Geng; Can Qi; Yunde Liu; Dan Yue
Journal:  Tumour Biol       Date:  2015-04-17

Review 2.  Interplay of retinal determination gene network with TGF-β signaling pathway in epithelial-mesenchymal transition.

Authors:  Yu Liu; Deguang Kong; Hua Wu; Xun Yuan; Hanxiao Xu; Cuntai Zhang; Gaosong Wu; Kongming Wu
Journal:  Stem Cell Investig       Date:  2015-06-09

3.  Cancer stem cells: constantly evolving and functionally heterogeneous therapeutic targets.

Authors:  Tao Yang; Kiera Rycaj; Zhong-Min Liu; Dean G Tang
Journal:  Cancer Res       Date:  2014-04-08       Impact factor: 12.701

4.  High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancer.

Authors:  Xuebing Yan; Leilei Yan; Jia Zhou; Sihong Liu; Zezhi Shan; Chunyu Jiang; Yuan Tian; Zhiming Jin
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

5.  YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer.

Authors:  Dewei Jiang; Ting Qiu; Junjiang Peng; Siyuan Li; Wenlong Ren; Chuanyu Yang; Yi Wen; Chuan-Huizi Chen; Jian Sun; Yingying Wu; Rong Liu; Jun Zhou; Kongming Wu; Wen Liu; Xiaoyun Mao; Zhongmei Zhou; Ceshi Chen
Journal:  Cell Death Differ       Date:  2022-01-13       Impact factor: 12.067

6.  Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide.

Authors:  Su-Hyeong Kim; Catherine H Kaschula; Nolan Priedigkeit; Adrian V Lee; Shivendra V Singh
Journal:  J Biol Chem       Date:  2016-04-29       Impact factor: 5.157

7.  SIX1 and DACH1 influence the proliferation and apoptosis of hepatocellular carcinoma through regulating p53.

Authors:  Qi Cheng; Deng Ning; Jin Chen; Xue Li; Xiao-Ping Chen; Li Jiang
Journal:  Cancer Biol Ther       Date:  2018-02-12       Impact factor: 4.742

8.  IMPDH1/YB-1 Positive Feedback Loop Assembles Cytoophidia and Represents a Therapeutic Target in Metastatic Tumors.

Authors:  Hailong Ruan; Zhengshuai Song; Qi Cao; Dong Ni; Tianbo Xu; Keshan Wang; Lin Bao; Junwei Tong; Haibing Xiao; Wen Xiao; Gong Cheng; Zhiyong Xiong; Huageng Liang; Di Liu; Liang Wang; Tredan Olivier; Boyle Helen Jane; Hongmei Yang; Xiaoping Zhang; Ke Chen
Journal:  Mol Ther       Date:  2020-03-10       Impact factor: 11.454

9.  Hepatocyte DACH1 Is Increased in Obesity via Nuclear Exclusion of HDAC4 and Promotes Hepatic Insulin Resistance.

Authors:  Lale Ozcan; Devram S Ghorpade; Ze Zheng; Jane Cristina de Souza; Ke Chen; Marc Bessler; Melissa Bagloo; Beth Schrope; Richard Pestell; Ira Tabas
Journal:  Cell Rep       Date:  2016-05-26       Impact factor: 9.423

Review 10.  A comprehensive review of the functions of YB-1 in cancer stemness, metastasis and drug resistance.

Authors:  Akram Alkrekshi; Wei Wang; Priyanka Shailendra Rana; Vesna Markovic; Khalid Sossey-Alaoui
Journal:  Cell Signal       Date:  2021-07-03       Impact factor: 4.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.